AC
KURA icon

AXQ Capital’s Kura Oncology KURA Stock Holding History

AXQ Capital’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$175K Sell
21,556
-5,400
-20% -$46.4K 0.02% 779
2025
Q4 		$280K Buy
+26,956
New +$283K 0.06% 461
2025
Q3 		– Sell
-45,472
Closed -$262K – 716
2025
Q2 		$262K Buy
45,472
+19,369
+74% +$119K 0.08% 401
2025
Q1 		$172K Buy
+26,103
New +$203K 0.07% 410
2023
Q4 		– Sell
-12,943
Closed -$118K – 743
2023
Q3 		$118K Buy
+12,943
New +$131K 0.04% 419

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AXQ Capital's KURA Position: Q1 2026 in Review

AXQ Capital reduced its Kura Oncology (KURA) stake by 20% in Q1 2026, selling an estimated $46.4K and leaving 21,556 shares worth $175K. The position accounts for 0.02% of the portfolio, ranked #779.

AXQ Capital first reported a position in KURA in Q3 2023 and has held it in 5 quarters since. The position peaked at $280K in Q4 2025. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • AXQ Capital held 21,556 shares of Kura Oncology worth $175K as of Q1 2026.
  • AXQ Capital sold 5,400 Kura Oncology shares in Q1 2026, an estimated $46.4K.
  • Kura Oncology made up 0.02% of AXQ Capital's portfolio in Q1 2026, its #779 holding.
  • AXQ Capital first reported a position in Kura Oncology in Q3 2023 and has held it in 5 quarters since.
  • AXQ Capital's Kura Oncology position peaked at $280K in Q4 2025.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.